Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Iron isotope |
Is a |
False |
Iron |
Inferred relationship |
Some |
|
Focal hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Hemosiderosis, acquired |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Corneal rust ring |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron pigmentation of oral mucosa |
Causative agent (attribute) |
True |
Iron |
Inferred relationship |
Some |
2 |
Serum iron measurement |
Has measured component (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Total iron binding capacity |
Measures |
False |
Iron |
Inferred relationship |
Some |
|
Iron adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron and folic acid adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Polysaccharide iron complex adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Sodium ironedetate adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Compound iron preparations adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron sorbitol adverse reaction (disorder) |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous salt adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous gluconate adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous glycine sulfate adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous succinate adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous phosphate adverse reaction |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Red cell iron utilization study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
3 |
Total body iron with chelatable radioiron study |
Has measured component (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Total body iron with chelatable radioiron study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Siderosis of eye |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
2 |
Iron measurement, liver tissue |
Has measured component (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron kinetics study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Hereditary hemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Secondary hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Idiopathic pulmonary hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron measurement |
Has measured component (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron measurement, urine |
Has measured component (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
maladie pulmonaire des polisseurs d'argent |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
An early-onset and most severe form of rare haemochromatosis characterised by the usual features of haemochromatosis accompanied by cardiomyopathy and hypogonadism. |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Secondary hemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Restrictive cardiomyopathy secondary to hemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Radioiron body distribution study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron overload |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Neonatal hemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Pulmonary siderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
African nutritional hemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Transfusion hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Shunt hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Erythropoietic hemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Dilated cardiomyopathy due to haemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Renal hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Hepatic hemosiderosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Hemochromatosis |
Causative agent (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Radioiron oral absorption study |
Has measured component (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron absorption measurement |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron clearance measurement |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron utilization measurement |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
24 hour urine iron output measurement |
Has measured component (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron kinetics NOS |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron absorption measurement |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Serum iron measurement |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Total body iron with chelatable radioiron study |
Component |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron measurement, liver tissue |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Iron measurement |
Component |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron measurement, urine |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Radioiron oral absorption study |
Component |
False |
Iron |
Inferred relationship |
Some |
|
24 hour urine iron output measurement |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing iron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing iron dextran (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Iron-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing ferrous gluconate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing iron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
Oral iron for iron-deficiency anemias |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing precisely ferrous fumarate 305 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate 322 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate 210 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate 140mg/5mL sugar free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate 140mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous gluconate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous glycine sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrocontin Continus 562.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous glycine sulfate 562.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous succinate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 60mg/5mL pediatric oral solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 150mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 325mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 116mg/mL drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 160mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing folic acid and iron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
Ferrous sulfate+folic acid 150mg/500micrograms m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate+folic acid 325mg/350micrograms m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferric ammonium citrate+folic acid 80mg/500micrograms/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate+folic acid 160mg/400micrograms m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferric ammonium citrate+folic acid 80mg/2.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing sodium feredetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Compound iron preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Parenteral form iron for iron-deficiency anemias |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing iron sorbitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Iron sorbitol (50mg/mL Ferrous iron) injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Iron hydroxide sucrose complex |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Iron hydroxide sucrose complex 100mg/5mL(Fe) intravenous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|